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a  b  s  t  r  a  c  t
In Dakar  kennels  where  morbidity  and  mortality  attributed  to diseases  transmitted  by  ticks
were high,  we  conducted  a  ﬁeld study  to assess  the  prevalence  of  Ehrlichia  canis,  Anaplasma
platys  and Babesia  spp. infections  in two  kennels  (n =  34  dogs)  and  to study  the  impact  of
tick  protection.  The  ﬁrst day  of the  study,  the E.  canis  PCR  were  positive  in  18  dogs  (53%).  A.
platys  was found  in one  dog  and all dogs  were  negative  for  Babesia  spp.  After  one  month  of
doxycycline  treatment,  the  number  of PCR  positive  dogs  decreased  signiﬁcantly  to 2  (5.9%).
During  seven  months,  all dogs  were  treated  monthly  topically  with  a  novel  combination
(Certifect®, Merial)  delivering  at least  6.7  mg ﬁpronil/kg  body  weight,  8.0 mg amitraz/kg






the seven  months,  with  4 dogs  being  positive  at  Day  90  and 2  at Day  210.  The  combination
of  treatment  and  monthly  prevention  had  a signiﬁcant  effect  in  the two kennels.  All  dogs
remained  healthy,  which  was  not  the case  in  previous  years.
© 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-SA license. . IntroductionDakar, capital of Senegal, located on the western edge
f Africa, is a city of over one million inhabitants, where
uch of the country’s economic activity is concentrated.
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Open access under CC BYPopulation growth is constant and requires organizing the
protection of individuals and their households. For this pur-
pose, the use of working dogs to prevent delinquency is
common. The Senegalese Gendarmerie has a special unit
in Dakar with handlers and trained dogs. In addition, sev-
eral private companies have set up protection units with
dogs. These dogs live in kennels in an environment suscep-
tible to external parasites especially ticks. As the climate is
tropical, Dakar is exposed to the development of the brown
dog tick, Rhipicephalus sanguineus.  The hot and humid sea-
son lasts from June to October with temperatures around
27 ◦C and a peak rainfall in August (250 mm)  when the
-NC-SA license. 
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vegetation is abundant. During the dry season, the risk of
tick infestation decreases but does not disappear.
R. sanguineus,  the brown dog tick, is the most
widespread species in Dakar, especially in kennels where
it readily colonizes the infrastructure (walls, ﬂoors, etc.).
It is responsible for the transmission of Ehrlichia canis in
dogs, the agent of canine monocytic ehrlichiosis. Cases
of ehrlichiosis have been already diagnosed by indirect
immunoﬂuorescence (IFA), in Dakar kennels where mor-
bidity and mortality were high [1,2].
In this context, it seemed interesting to carry out for
the ﬁrst time in Senegal, a ﬁeld study of the prevalence
of E. canis infections and other pathogens in natural con-
ditions in the kennels located in Dakar and to study the
impact of tick protection. All guard dogs living in these ken-
nels were included. The two kennels and the activity of the
dogs were supposed to be different in terms of tick chal-
lenge. The dogs were ﬁrst treated by the administration of
doxycycline (Ronaxan®, Merial, France) for one month and,
simultaneously, the prevention of tick infestation through
the application of a spot-on (Certifect®, Merial, France) was
put in place for a period of 7 months. The health status but
also the serological and blood PCR results were followed
during a period of 7 months.
2. Materials and methods
2.1. Dogs
In 2012, two groups of working dogs were studied (34
dogs in total) living in two kennels located in different
neighbourhoods of Dakar (Fig. 1). The kennels chosen were
the largest in Dakar. Kennel 1, located at Marinas Hann and
in which 20 dogs were born in Dakar, belongs to a pri-
vate enterprise and is composed of 6 males and 14 females,
aged 6 months to 9 years (mean 2.5 years). They were Ger-
man Shepherds (5), Belgian Shepherds (2), cross-Belgian
Shepherds–German Shepherds (9) and cross-Beauce Shep-
herds (4). In this group, the dogs were irregularly treated
against ticks before the start of the study. Tick infestation
was often reported and clinical cases attributable to ehrli-
chiosis were frequently observed (two fatal cases during
the year preceding the study) (Fig. 2). Dogs live an aver-
age of two per enclosure. They are properly fed and cared
for. These dogs always work in industrial areas of Dakar,
where they have access to bush areas corresponding to the
biotope of R. sanguineus.  They are also located near the sea
and have regular access to water. The second group of dogs
belongs to the Senegalese Gendarmerie whose kennel 2 is
located in the district of Mbao. It includes 14 male dogs (12
Belgian Shepherds and 2 German Shepherds) aged 2.5–11
years (mean 7 years). All dogs were purchased in Belgium
(12 dogs), France (1 dog), or Italy (1 dog) and they arrived
in Dakar at the age of two to three years. In this kennel,
the dogs were closely monitored. They were groomed daily
and were regularly bathed with acaricides (amitraz) before
the start of the study. However, cases of tick infestation
were common and infection with E. canis responsible for
the death of a dog shortly before the application of our
protocol was reported. These dogs hardly go outside their
kennel and have no access to the sea.gy and Infectious Diseases 36 (2013) 613– 617
2.2. Protocol of the study
The ﬁrst day of the study (Day 0) and two months later
(D 60), all dogs were examined by a veterinarian. They
were in apparent good health. No tick was  found. Blood
samples (serum and EDTA) were collected from all dogs.
The samples with EDTA were transported to the laboratory
in France (VetAgro Sup, Veterinary Campus, Marcy l’Etoile,
France) in a cold package. From Day 0 to Day 30, all dogs
were treated daily, per os,  with doxycycline hyclate (100 mg
Ronaxan®, Merial, Lyon, France). At Days 0, 30, 60, 90, 120,
180 and Day 210 all dogs were treated topically with a
novel combination (Certifect®, Merial) based on 2 formu-
lations delivering at least 6.7 mg  ﬁpronil/kg body weight,
8.0 mg/kg amitraz and 6 mg/kg (S)-methoprene. The spot-
on formulations were concurrently applied directly to the
skin at two locations along the dorsal midline of the neck,
one spot in front of the shoulder blades and one at mid-
neck. In both kennels, the dogs were regularly followed up
for health purposes. Their handlers examined them daily
for the possible detection of ticks. In case of presence of
ticks, they were preserved in alcohol at 70◦. Blood samples
were taken from the dogs at days 0, 60, 90, and 180 and
collected in EDTA tubes.
The main goal of the study was to evaluate the feasibility
of the preventive protocol in the natural condition in the
tropical Africa. We  did not include the placebo-controlled
group of dogs in the study because of the ethical reasons
(working dogs could not be stayed without treatment in
the very aggressive environment).
2.3. Extraction of DNA from samples
DNA was  extracted from 200 L of blood using a
commercial DNA extraction kit (QIAamp DNA Mini Kit®)
according to the manufacturer’s instructions (Qiagen,
Hilden, Germany). DNA was  eluted with 80 L of speciﬁc
buffer.
2.4. PCR ampliﬁcation
A multiplex PCR ampliﬁcation was  performed from
each DNA blood sample to conﬁrm the presence of dog
DNA by using primers that speciﬁcally amplify a 290-bp
fragment of the mitosin gene of Canis familiaris, as previ-
ously described [3]. This ampliﬁcation is used to valid DNA
extraction. The presence of one or more pathogens was  able
to be detected by using primers: a 380-bp fragment of virB9
protein gene of E. canis, a 619-bp fragment of 18S rRNA
gene of Babesia or Theileria spp as previously described [4],
and a 515-bp fragment of groEL gene of Anaplasma platys
as previously described [5]. The ampliﬁcation reaction was
carried out in a thermocycler (Biometra® T gradient, Goet-
tingen, Germany) in a total of 25 L containing 1.25 L of
2 M of each primer, 12.5 L of 2x Type-it Multiplex PCR
Master mix  (Qiagen® Multiplex PCR Kit, Qiagen, Hilden,
Allemagne), 1 L DNA and 9 L of RNase free water. The
following conditions were applied: 95 ◦C 5 min, 35 cycles at
95 ◦C 30 s, 61 ◦C 90 s, 72 ◦C 30 s and 60 ◦C 30 min. A negative
control (reaction mix  without DNA) and a positive control
(mix of pathogens DNA and dog DNA) were systematically





















rFig. 1. Localization of the
ncluded in parallel. An aliquot of each ampliﬁed product
as separated on 1.5% agarose gel stained with Ethidium
romide at 130 V for 1 h. The bands were visualized under
ltraviolet illumination.
.5. Serology
The sera were tested at Days 0, 60, 90 and 210 with one
apid immuno-migration (RIMTM) quick test that detects
. canis antibodies (Witness® Ehrlichia, Synbiotics, Lyon,
rance). Sensitized colloidal gold particles bound to anti-E.
anis antibodies present within the sample (whole blood,
erum or plasma) are allowed to migrate along a strip.
he complex is then captured on a sensitized reaction line
here its accumulation causes the formation of a clearly
isible pink band. A control band, located at the end of
he reading window, ensures that the test was performed
orrectly.
. Results
During the 6-month study period, all dogs remained
ealthy, which was not the case in previous years (Fig. 2).
he original treatment of the dogs and the monthly anti-
ick prevention provided a complete control of any clinical
esurgence of ehrlichiosis.
Fig. 2. Deaths and cases attributed to infecnd the two dog kennels.
During the survey we were able to collect ticks from
dogs (only in kennel 1). In total, 45 ticks were found from
12 dogs. During the ﬁrst month of treatment we collected
31 ticks (including 9 engorged); the other 14 non engorged
ticks were found randomly during the next six months. All
ticks were morphologically identiﬁed as R. sanguineus tick
group adults using standard taxonomic keys for adult ticks
by one of us (FB). In kennel 2, no tick had been observed
in the dogs during the 7 months of daily follow-up. Based
on the mode of life of the dogs in both kennels, especially
knowing that kennel 1 dogs regularly go outside, it was
hypothesized that the tick challenge was  higher in kennel
1.
The seroprevalence of ehrlichiosis was  85% at the start
of the study (Table 1). After 1-month treatment, the sero-
prevalence remained at 85% and was  even at 94% at the end
of the 7 months. The 30 days of doxycycline had no impact
on the serological status in either kennel. There is also no
statistical difference between the two groups and between
seroprevalences all along the 7 months (p = 0.98).
The ﬁrst day of the study (Day 0), the PCR were posi-
tive in 18 dogs (53%) (Table 1). A. platys was found by PCR
analysis in one dog (also positive for E. canis). All other PCR
were positive for E. canis only. PCR examinations for Babesia
spp. were negative in all cases. After one month of doxycy-
cline treatment, the number of PCR positive dogs decreased
tious diseases in kennels 1 and 2.
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Table  1
Serology and molecular detection of Ehrlichia canis during seven months.
Kennel Localization in Dakar No. of dogs in
the study
Detection of Ehrlichia canisa
D 0 D 60 D 90 D 210
PCR Serologyb PCR Serologyb PCR Serologyb PCR Serologyb
1 Hann Marinas 20 9(45%) 15 (75%) 2 (10%) 15 (75%) 4 (20%) 17 (85%) 2 (10%) 18 (90%)
2  Mbao 14 9(64%) 14 (100%) 0 (0%) 14 (100%) 0 (0%) 14 (100%) 0 (0%) 14 (100%)
Total  34 18(53%) 29 (85%) 2 (6%) 29 (85%) 4 (12%) 31 (91%) 2 (6%) 32 (94%)a Positive samples.
b Rapid immuno-migration (Witness® Ehrlichia).
signiﬁcantly to 2 (5.9%) (p < 2 × 10−5), indicating a reduc-
tion of 88.88%. This number of PCR positive dogs remained
stable all over the 7 months, with 4 dogs being positive at
Day 90 and 2 at Day 210. The combination of treatment
and monthly prevention had a signiﬁcant effect in kennel
1 (p < 0.02) and kennel 2 (p < 10−7). There was no statistical
difference in effect between kennel 1 and 2 despite a trend
for a better protection seen in kennel 1.
We have recorded the differences in the dynamics of the
detection of E. canis between two kennels. In the kennel 2
all dogs that were positive in the beginning of the study
became negative from the Day 90. However, in the kennel
1, only 6 of 11 dogs became PCR-negative during the study
from the Day 90. 2/11 also became negative, but only from
Day 210. Another 2 dogs, vice versa, became positive by
PCR beginning from the Day 90 and one initially positive
was found negative at the Day 90 and positive at the Day
210.
4. Discussion
Canine monocytic ehrlichiosis (CME) has been reported
in Africa (Congo, Sudan, Niger, South Africa, Tunisia,
Kenya). CME  is transmitted by the brown dog-tick (R. sang-
uineus). It is ubiquitous below the 45th parallel north and
corresponds to the area of distribution of this tick. This
species is especially endophilic, it is often found in ken-
nels and crevices of walls. The seroprevalence of CME  is
very high throughout Africa where it may  be considered
enzootic. The prevalence of E. canis in R. sanguineus ticks in
African countries was reported in Cameroon with 6 to 21%
of PCR+ ticks [6] and in Ivory Coast with 7 to 47% in ticks
collected from watchdogs in Abidjan [7] .The author previ-
ously found that over 77% of dogs in eight farms (64 dogs) in
Abidjan (Ivory Coast) became seropositive during the ﬁrst
year [8]. Native African dogs are often asymptomatic, while
imported dogs that do not have acquired immunity often
develop severe clinical forms. The results of this study (85%
of seroprevalence) are comparable to those we obtained
with IFA test in Libreville (Gabon) (83% of 80 dogs) [9]. In
kennel 2 of the Senegalese Gendarmerie, all dogs (100%)
were seropositive whereas in the same kennel, in 1990,
the seroprevalence rate was already high (78%) [1]. The
persistence of anti-E. canis antibodies after treatment is
well known, but it is not certain whether the antibodies
are markers of chronic infection [10] or of regular reinfec-
tions. The fact that ticks were observed may  be in favour ofregular antigen contact and reboost for antibody produc-
tion. It indicates that the anti-tick prevention was  not able
to avoid any antigen contact, therefore the attachment of a
few ticks on dogs.
The PCR is currently used to estimate the prevalence of
DNA of E. canis in dog’s blood. In Cameroon, 14.4% (15/104)
of dogs were positive and all had attached ticks [11]. In
Sudan, the prevalence estimated by molecular methods
was  80.8% (63/78) among village dogs, and R. sanguineus
were found on all of them [12].
Our study is one of the rare ﬁeld studies in the tropi-
cal Africa in the natural conditions. The main result of our
study is the approval of the feasibility of the application
of the basic prevention protocol in the natural condition
and the conﬁrmation of already known protective effects
of the Certifect®. Our results indicate also that appropriate
doxycycline treatment eliminates E. canis and A. platys DNA
as measured by PCR. It has been shown that PCR is a good
indicator of the persistence of E. canis in different tissues of
the dog [13]. Experimentally, it has been shown that PCR
becomes negative in the blood [14]. However, we also know
that the infection may  persist even after 6 weeks of treat-
ment with doxycycline [15]. The most recent experimental
studies show that one month with doxycycline treatment
produces a negative PCR in blood in the long-term (211
days), even after immunosuppression [16].
Regular anti-tick treatments are known to help in
decreasing the risk of disease transmission. Davoust et al.
[17] and Otranto et al. [18] demonstrated respectively that
the use of Frontline® and Advantix® gave a certain level
of protection to dogs against E. canis infection in ﬁeld tri-
als in Africa and in Italy. It was demonstrated recently that
Certifect® induced an indirect protection against the trans-
mission of E. canis using an experimental model based on
a strain of E. canis infected R. sanguineus [19]. The com-
bination of ﬁpronil and amitraz increases the speed of
kill and disrupts the attachment of ticks, therefore pro-
viding a better preventive effect against the transmission
of pathogens by ticks than ﬁpronil alone. In this 7-month
study, Certifect® provided a 88.9% signiﬁcant protection in
kennel dogs with a PCR positive rate decreasing from 53%
to 6% (p < 2 × 10−5). This protection was  77.77% in kennel
1 (p = 0.013) and 100% in kennel 2 with a percentage of
PCR dogs decreasing from 64% to 0% (p = 0.00027), which
demonstrates that several factors may  affect the protective
efﬁcacy, especially the level of tick challenge. Effectively,
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tudy are due to the fact that kennel 1 was very infested.
he lifestyle of dogs of this kennel is also a factor of expo-
ure to ticks because of the random contact with different
ick-infested areas and frequent changes of handlers. Fur-
hermore, these dogs were probably taken to sea baths
hich could reduce the effectiveness of preventive treat-
ent.
Overall, this study shows that the doxycycline treat-
ent eliminates the ehrlichia carriage in dogs and that
reventive treatment protects dogs from the tick-borne
nfections, reducing the mortality and morbidity due to
nfectious diseases.
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